Compared side by side
HGH vs ipamorelin: how they differ
The short answer
HGH is recombinant growth hormone itself, injected daily; ipamorelin is a ghrelin receptor agonist that prompts the pituitary to release its own GH, without raising cortisol in animal studies, taken 2–3 times a day. HGH is FDA-approved for GH deficiency and several growth disorders, but not for aging or athletic use; ipamorelin was never approved, and its human data are a small GH study and phase 2 trials in surgical patients. Commonly reported: water retention and joint aches on HGH, and deeper sleep and vivid dreams first on ipamorelin.
Side by side
| Compared | HGH | Ipamorelin |
|---|---|---|
| Category | Growth hormone | Growth hormone |
| Also known as | GH, rHGH, Human Growth Hormone, Growth Hormone, Somatropin, hGH | IPAM |
| What it is | Recombinant human growth hormone — an identical copy of the GH your pituitary makes. | Considered the 'cleanest' growth hormone stimulator: in animal studies it triggers the pituitary to release GH without raising cortisol, a side effect common with other GH peptides. |
| How it works | Recombinant human growth hormone. Binds GH receptors to stimulate IGF-1 production, protein synthesis, and lipolysis. Promotes muscle growth, fat oxidation, and tissue repair. Structurally identical to pituitary GH, though injections don't reproduce its natural pulses. | Selective growth hormone secretagogue and ghrelin receptor agonist. In animal studies it released GH without raising cortisol or ACTH, and users report milder hunger than with GHRP-6. Considered one of the cleanest GH pulses available. |
| Commonly reported | Water retention, numb or tingling fingers, joint aches, and better sleep and skin. Requires careful dosing and IGF-1 monitoring — more is not always better. | Deeper sleep and vivid dreams first, then better recovery, skin quality and gradual body-composition changes, with milder hunger than GHRP-6. Its human data are a small GH study and phase 2 trials in surgical patients; it was never approved. |
| Studied range | Research range: 1–4 IU. Studied in research — not a recommendation. | Research range: 200–300 mcg, starting dose 200 mcg. Studied in research — not a recommendation. |
| How often | Daily SubQ injection. | 2–3x daily, best fasted or before bed |
| Half-life | ~3-4 hours (SubQ) | ~2 hours (measured in healthy men, given IV) |
| Route | SubQ injection | SubQ injection, IM injection |
| Typical run | Commonly reported starting dose 1-2 IU daily. Advanced users may run 3-4 IU split AM/PM. Cycles of 3-6+ months common. Monitor IGF-1 levels. Also run alongside peptide stacks; some advanced protocols add insulin, which isn't in this library. | Commonly 8–12 weeks on, 4 weeks off to avoid receptor desensitisation. Some run longer with breaks. |
| Evidence | Established: clinical trials or FDA-approved use exists | Moderate: animal studies + some human data |
| Common side effects | Water retention, joint pain, carpal tunnel syndrome, morning fatigue, injection site reactions | Headache, flushing, nausea, water retention, numbness/tingling |
- Category
- HGHGrowth hormone
- IpamorelinGrowth hormone
- Also known as
- HGHGH, rHGH, Human Growth Hormone, Growth Hormone, Somatropin, hGH
- IpamorelinIPAM
- What it is
- HGHRecombinant human growth hormone — an identical copy of the GH your pituitary makes.
- IpamorelinConsidered the 'cleanest' growth hormone stimulator: in animal studies it triggers the pituitary to release GH without raising cortisol, a side effect common with other GH peptides.
- How it works
- HGHRecombinant human growth hormone. Binds GH receptors to stimulate IGF-1 production, protein synthesis, and lipolysis. Promotes muscle growth, fat oxidation, and tissue repair. Structurally identical to pituitary GH, though injections don't reproduce its natural pulses.
- IpamorelinSelective growth hormone secretagogue and ghrelin receptor agonist. In animal studies it released GH without raising cortisol or ACTH, and users report milder hunger than with GHRP-6. Considered one of the cleanest GH pulses available.
- Commonly reported
- HGHWater retention, numb or tingling fingers, joint aches, and better sleep and skin. Requires careful dosing and IGF-1 monitoring — more is not always better.
- IpamorelinDeeper sleep and vivid dreams first, then better recovery, skin quality and gradual body-composition changes, with milder hunger than GHRP-6. Its human data are a small GH study and phase 2 trials in surgical patients; it was never approved.
- Studied range
- HGHResearch range: 1–4 IU. Studied in research — not a recommendation.
- IpamorelinResearch range: 200–300 mcg, starting dose 200 mcg. Studied in research — not a recommendation.
- How often
- HGHDaily SubQ injection.
- Ipamorelin2–3x daily, best fasted or before bed
- Half-life
- HGH~3-4 hours (SubQ)
- Ipamorelin~2 hours (measured in healthy men, given IV)
- Route
- HGHSubQ injection
- IpamorelinSubQ injection, IM injection
- Typical run
- HGHCommonly reported starting dose 1-2 IU daily. Advanced users may run 3-4 IU split AM/PM. Cycles of 3-6+ months common. Monitor IGF-1 levels. Also run alongside peptide stacks; some advanced protocols add insulin, which isn't in this library.
- IpamorelinCommonly 8–12 weeks on, 4 weeks off to avoid receptor desensitisation. Some run longer with breaks.
- Evidence
- HGHEstablished: clinical trials or FDA-approved use exists
- IpamorelinModerate: animal studies + some human data
- Common side effects
- HGHWater retention, joint pain, carpal tunnel syndrome, morning fatigue, injection site reactions
- IpamorelinHeadache, flushing, nausea, water retention, numbness/tingling
Typical run: Community practice — opinions vary. Not a clinical recommendation.

Week by week
Each entry’s cards by day window, as the compound pages show them. Day 1 is the day you start it.
HGH
Week-by-week cards for HGH are not in our library.
Ipamorelin
- Day 1–14 Sleep is deepening
- Day 14–28 Recovery is noticeably faster
- Day 28–56 Body composition shifts showing up
- Day 56–84 Cycle-end + planned break
Questions people ask
How long do HGH and ipamorelin last?
The half-life of HGH is ~3-4 hours (SubQ). The half-life of ipamorelin is ~2 hours (measured in healthy men, given IV).
How often are HGH and ipamorelin taken?
HGH: daily SubQ injection. Route: SubQ injection. Ipamorelin: 2–3x daily, best fasted or before bed. Routes: SubQ injection, IM injection.
How are HGH and ipamorelin dosed in research?
The research range for HGH is 1–4 IU. The research range for ipamorelin is 200–300 mcg, with a 200 mcg starting dose. Studied in research — not a recommendation.
What are the common side effects of HGH and ipamorelin?
For HGH, the library lists: water retention, joint pain, carpal tunnel syndrome, morning fatigue, injection site reactions. For ipamorelin: headache, flushing, nausea, water retention, numbness/tingling.